Natural, Semisynthetic, and Synthetic Antiviral Drugs Targeting HIV and SARS-CoV-2
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 54
Special Issue Editors
2. Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil
Interests: viral evolution; drug design; drug development; synthesis; natural products; repurposing drugs; chemico-biological interactions; preclinical models; enzymology; in silico calculations
Special Issues, Collections and Topics in MDPI journals
Interests: virus-host interactions; photo-responsive compounds; photodynamic therapy; biophysical analysis; spectroscopy; high-throughput screening
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Viruses cause massive public health concerns, mainly due to their mutagenesis, which might result in spillovers, escape of the humoral response, and drug resistance. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the human immunodeficiency virus (HIV) are two distinct viruses that cause different diseases and have various modes of action, transmission, and impact on human health. The first one is a respiratory virus of the genus betacoronavirus that causes the coronavirus disease 2019 (COVID-19; severe cases of this condition may require hospitalization), while the other is a retrovirus belonging to the genus lentivirus that might cause acquired immunodeficiency syndrome (AIDS, which leads to opportunistic infections and cancers if left untreated). While HIV/AIDS remains a chronic, manageable condition with ongoing prevention and treatment efforts, SARS-CoV-2 has highlighted the acute need for rapid response and vaccination to control a pandemic. Since both HIV and SARS-CoV-2 have had profound impacts on global health, albeit in different ways, advances in medicine and public health continue to evolve in response to these viruses, aiming to reduce transmission, morbidity, and mortality associated with these infectious diseases.
In this sense, to achieve an up-to-date point of view of antiviral development to target HIV or SARS-CoV-2, this Special Issue focuses on the recent scientific and technical progress made in medicinal chemistry. Based on your extensive knowledge and experience, we are pleased to invite you to contribute original research articles to promote and highlight the discovery and importance of antivirals through multidisciplinary tasks involving (but not limited to) virology, biophysics, biochemistry, biology, and chemistry. Review articles are also welcome, especially those describing trends and challenges in antiviral discovery, biophysical characterization of the interaction target antivirals, antiviral mechanisms, and analytical chemistry applied to virology.
We look forward to receiving your contributions.
Dr. Otávio Augusto Chaves
Dr. Carlos Serpa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiviral design and discovery
- natural product screening
- natural products as a scaffold for semisynthetic antivirals
- repurposing drugs
- high-throughput screening
- antiviral resistance
- biophysical characterization of the interaction between antivirals and targets
- combination of light and photosensitizers in antiviral discovery
- cell-based and in vivo assays
- in silico calculations
